Severe Liver Injury Triggered by Sequential Use of Immune Checkpoint Blockers and Tyrosine Kinase Inhibitors: An Emerging Clinical Issue

J Thorac Oncol. 2023 Oct;18(10):e112-e113. doi: 10.1016/j.jtho.2023.07.002.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents, Immunological*
  • Humans
  • Immune Checkpoint Inhibitors
  • Liver
  • Lung Neoplasms*
  • Protein Kinase Inhibitors / adverse effects
  • Tyrosine Kinase Inhibitors

Substances

  • Immune Checkpoint Inhibitors
  • Tyrosine Kinase Inhibitors
  • Antineoplastic Agents, Immunological
  • Protein Kinase Inhibitors